{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,8,26]],"date-time":"2025-08-26T01:10:19Z","timestamp":1756170619341,"version":"3.44.0"},"reference-count":7,"publisher":"Elsevier BV","issue":"8","license":[{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","mayoclinicproceedings.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Mayo Clinic Proceedings"],"published-print":{"date-parts":[[2025,8]]},"DOI":"10.1016\/j.mayocp.2025.04.013","type":"journal-article","created":{"date-parts":[[2025,7,3]],"date-time":"2025-07-03T12:16:17Z","timestamp":1751544977000},"page":"1439-1441","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Risk Factors and Outcomes of Patients With Cholangiocarcinoma and Primary Sclerosing Cholangitis"],"prefix":"10.1016","volume":"100","author":[{"given":"Srija","family":"Manchkanti","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9638-3629","authenticated-orcid":false,"given":"Udhayvir Singh","family":"Grewal","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"6","key":"10.1016\/j.mayocp.2025.04.013_bib1","doi-asserted-by":"crossref","first-page":"2045","DOI":"10.1002\/hep.26565","article-title":"Population-based epidemiology, malignancy risk, and outcome of primary sclerosing cholangitis","volume":"58","author":"Boonstra","year":"2013","journal-title":"Hepatology"},{"issue":"12","key":"10.1016\/j.mayocp.2025.04.013_bib2","doi-asserted-by":"crossref","first-page":"1161","DOI":"10.1056\/NEJMra1506330","article-title":"Primary sclerosing cholangitis","volume":"375","author":"Lazaridis","year":"2016","journal-title":"N Engl J Med"},{"issue":"1","key":"10.1016\/j.mayocp.2025.04.013_bib3","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1186\/s12876-023-02759-7","article-title":"Predicting cholangiocarcinoma in primary sclerosing cholangitis: using artificial intelligence, clinical and laboratory data","volume":"23","author":"Hu","year":"2023","journal-title":"BMC Gastroenterol"},{"issue":"6","key":"10.1016\/j.mayocp.2025.04.013_bib4","doi-asserted-by":"crossref","first-page":"659","DOI":"10.3748\/wjg.v25.i6.659","article-title":"Cancer risk in primary sclerosing cholangitis: epidemiology, prevention, and surveillance strategies","volume":"25","author":"Fung","year":"2019","journal-title":"World J Gastroenterol"},{"issue":"14","key":"10.1016\/j.mayocp.2025.04.013_bib5","doi-asserted-by":"crossref","first-page":"3483","DOI":"10.3390\/cancers14143483","article-title":"Association between metabolic disorders and cholangiocarcinoma: impact of a postulated risk factor with rising incidence","volume":"14","author":"Da Fonseca","year":"2022","journal-title":"Cancers (Basel)"},{"issue":"5","key":"10.1016\/j.mayocp.2025.04.013_bib6","doi-asserted-by":"crossref","first-page":"797","DOI":"10.1097\/SLA.0000000000002574","article-title":"Transplantation versus resection for hilar cholangiocarcinoma: an argument for shifting treatment paradigms for resectable disease","volume":"267","author":"Ethun","year":"2018","journal-title":"Ann Surg"},{"key":"10.1016\/j.mayocp.2025.04.013_bib7","doi-asserted-by":"crossref","DOI":"10.3389\/ti.2022.10802","article-title":"Outcomes after liver transplantation with incidental cholangiocarcinoma","volume":"35","author":"Safdar","year":"2022","journal-title":"Transpl Int"}],"container-title":["Mayo Clinic Proceedings"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0025619625002198?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0025619625002198?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,8,26]],"date-time":"2025-08-26T00:29:53Z","timestamp":1756168193000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0025619625002198"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,8]]},"references-count":7,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2025,8]]}},"alternative-id":["S0025619625002198"],"URL":"https:\/\/doi.org\/10.1016\/j.mayocp.2025.04.013","relation":{},"ISSN":["0025-6196"],"issn-type":[{"type":"print","value":"0025-6196"}],"subject":[],"published":{"date-parts":[[2025,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Risk Factors and Outcomes of Patients With Cholangiocarcinoma and Primary Sclerosing Cholangitis","name":"articletitle","label":"Article Title"},{"value":"Mayo Clinic Proceedings","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.mayocp.2025.04.013","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Mayo Foundation for Medical Education and Research. Published by Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}